AbCellera
BC - VancouverBiotechnology
Focus: AbCellera is a therapeutic antibody discovery company leveraging advanced platform technology to identify and develop monoclonal antibodies across multiple disease areas. Founded in 2015 and headquartered in Vancouver, BC, the company operates at mid-cap biotech scale with 501–1000 employees.
Profile data last refreshed 24m ago · AI intelligence enriched 2w ago
Employees
501-1000
Open Jobs
17-1 this month
Stable — net -1 jobs in 30d
7 added, 8 removed. Backfill posture.
Should You Work at AbCellera?
AI assessmentA high-potential platform biotech with validating partnerships but unproven late-stage execution; suited for scientists betting on discovery-to-development leverage rather than near-term commercial upside.
Why Work Here
- Platform-driven antibody discovery with multi-therapeutic-area reach (Ophthalmology, Infectious Diseases, Immunology, Neurology, Oncology) signals sustained R&D investment and diverse career progression pathways.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for AbCellera
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.